Delivery Order SPE2DR25D3201-SPE2DR26FT6BT
- Not listed
- The Defense Logistics Agency awarded a $7,691 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 ml syringes on January 29, 2026, with completion scheduled for February 20, 2026. This is a non-set-aside contract awarded through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The contract was...
- The Defense Logistics Agency awarded a $7,691.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity) on December 30, 2025, with an ultimate completion date of January 22, 2026. This non-set-aside award was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $11.5K delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by November 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the same municipality....
- The Defense Logistics Agency awarded a $11,536.50 delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Gel-One 30 mg/3 mL syringes. This is a firm fixed-price contract with an ultimate completion date of February 13, 2026, and represents a non-competitive set-aside award. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. As a child entity of parent company Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $4,013.90. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,298.00 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity). The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of October 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $3,649.00 delivery order contract to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity) with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this...
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on June 20, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price, non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $18,245 delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on August 7, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The company, headquartered in Conshohocken,...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT6BTDelivery Order
The Defense Logistics Agency awarded a $7,691 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Gel-One 30 mg/3 ml syringes (3 ml units). This delivery order, which represents a non-set-aside competitive award, is scheduled for completion by February 20, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical valued at up to $999,999,999 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, covering specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and related medical commodities. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. As a wholly owned subsidiary of Cencora, Inc., the company demonstrates substantial capability in fulfilling government contracts for essential pharmaceutical and medical commodities through competitive procurement processes. The award of this delivery order for Gel-One syringes—an ophthalmic injectable product—reflects AmerisourceBergen's continued role in supplying specialized medical products to support military treatment facilities and federal healthcare programs. The relatively short delivery timeline of approximately three weeks indicates this represents a routine fulfillment under the established IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 1/28/26 |